Delivery Order SPE2DB22D7065-SPE2DB26FH0MR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML) on September 10, 2025, with a ceiling value of $13,268.58. This firm fixed-price delivery order, which carries an ultimate completion date of September 11, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML) with a ceiling value of $1,614.81. This non-competitive, firm fixed-price delivery order was awarded on June 25, 2025, with completion scheduled for June 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, serving as the place of performance. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.66 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2 milliliter units. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not carry a set-aside designation, indicating it was competed among...
- The Defense Logistics Agency awarded a delivery order valued at $1,669.81 to AmerisourceBergen Drug Corp for RotaTeq Vaccine 2ml on August 20, 2025, with an ultimate completion date of August 21, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) with a ceiling value of $2,741.22. This firm fixed-price delivery order, issued on August 14, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract is set for completion by August 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of RotaTeq vaccine (2 mL formulation) valued at $16,350.33 under a firm fixed-price contract structure. This non-competitive delivery order is scheduled for completion by September 9, 2025, with performance occurring at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2mL) with a ceiling value of $3,162.59 under a firm fixed-price contract. This non-competitive delivery order, issued on October 31, 2025, with an ultimate completion date of November 3, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement from the agency's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.10 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML formulation) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of RotaTeq vaccine (2mL formulation) valued at $10,655.80. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award of the pharmaceutical product. The order is scheduled for ultimate completion on August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2 mL formulation) with a ceiling value of $1,470.48. The contract, awarded on April 24, 2025, is structured as a firm fixed price delivery order with an ultimate completion date of April 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it was competitively awarded on an open...
- SPE2DB22D7065Indefinite Delivery Contract
- SPE2DB22D7065-SPE2DB26FH0MRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of RotaTeq vaccine in 2 mL units, with a ceiling value of $1,370.61. This is a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, and represents a child contract issued under AmerisourceBergen's larger pharmaceutical supply vehicle. The award involves no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The RotaTeq vaccine procurement supports federal medical supply needs for military and veteran healthcare systems as part of DLA's broader pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/30/25 |